Is acamprosate calcium the same as PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE?

No. acamprosate calcium (ACAMPROSATE CALCIUM) and PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ACAMPROSATE CALCIUM or PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ACAMPROSATE CALCIUM to PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ACAMPROSATE CALCIUM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Compare ACAMPROSATE CALCIUM (acamprosate calcium) and PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE) — clinical data, side effects, and patient experiences.

ACAMPROSATE CALCIUM

acamprosate calcium, Campral · Substance Use Agent

How it works

12.1 Mechanism of Action The mechanism of action of acamprosate in maintenance of alcohol abstinence is not completely understood. Chronic alcohol exposure is hypothesized to alter...

Approved for

See full prescribing information

OralTablet

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE · Substance Use Agent

How it works

Other agent

Approved for

abuse

misuse

overdose

and death

OralTablet

Quick Comparison

ACAMPROSATE CALCIUMPENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Drug Class

Substance Use Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACAMPROSATE CALCIUM

Low Blood Pressure

1-10%

Weakness

1-10%

Condition Worsened

1-10%

Fatigue

1-10%

Headache

1-10%

Depression

1-10%

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Diarrhea

1-10%

Drug Not Working

1-10%

Headache

1-10%

Nausea

1-10%

Tremor

1-10%

Anxiety

0.1-1%

Joint Pain

0.1-1%

High Blood Pressure

0.1-1%

FDA Warnings

ACAMPROSATE CALCIUM

5 WARNINGS AND PRECAUTIONS Dose reduction is required for patients with moderate renal impairment ( 5
Acamprosate calcium is contraindicated in patients with severe renal impairment (creatinine clearance of ≤30 mL/min) [ see Dosage and Administration (2

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF PENTAZOCINE AND NALOXONE TABLETS Addiction, Abuse, and Misuse Because the use of Pentazocine and Naloxone Tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [ see <WARNINGS ]
Life-Threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of Pentazocine and Naloxone Tablets, especially during initiation or following a dosage increase
To reduce the risk of respiratory depression, proper dosing and titration of Pentazocine and Naloxone Tablets are essential [ see <WARNINGS ]
Accidental Ingestion Accidental ingestion of even one dose of Pentazocine and Naloxone Tablets, especially by children, can result in a fatal overdose of Pentazocine Hydrochloride [ see <WARNINGS ]

Clinical Trial Data

No head-to-head clinical studies found for ACAMPROSATE CALCIUM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE.

ACAMPROSATE CALCIUM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE: What You Should Know

Key Differences

Both ACAMPROSATE CALCIUM and PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE belong to the Substance Use Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

ACAMPROSATE CALCIUM carries 2 FDA warnings. PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

NALTREXONE HYDROCHLORIDE vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE→ACAMPROSATE CALCIUM vs NALTREXONE HYDROCHLORIDE→NALOXONE HYDROCHLORIDE vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE→ACAMPROSATE CALCIUM vs NALOXONE HYDROCHLORIDE→DISULFIRAM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE→NALOXONE HYDROCHLORIDE NASAL vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ACAMPROSATE CALCIUM: DailyMed label · FAERS adverse events · ClinicalTrials.gov
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ACAMPROSATE CALCIUM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

ACAMPROSATE CALCIUM

acamprosate calcium, Campral · Substance Use Agent

How it works

12.1 Mechanism of Action The mechanism of action of acamprosate in maintenance of alcohol abstinence is not completely understood. Chronic alcohol exposure is hypothesized to alter...

Approved for

See full prescribing information

OralTablet

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE · Substance Use Agent

How it works

Other agent

Approved for

abuse

misuse

overdose

and death

OralTablet

Quick Comparison

ACAMPROSATE CALCIUMPENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Drug Class

Substance Use Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACAMPROSATE CALCIUM

Low Blood Pressure

1-10%

Weakness

1-10%

Condition Worsened

1-10%

Fatigue

1-10%

Headache

1-10%

Depression

1-10%

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Diarrhea

1-10%

Drug Not Working

1-10%

Headache

1-10%

Nausea

1-10%

Tremor

1-10%

Anxiety

0.1-1%

Joint Pain

0.1-1%

High Blood Pressure

0.1-1%

FDA Warnings

ACAMPROSATE CALCIUM

5 WARNINGS AND PRECAUTIONS Dose reduction is required for patients with moderate renal impairment ( 5
Acamprosate calcium is contraindicated in patients with severe renal impairment (creatinine clearance of ≤30 mL/min) [ see Dosage and Administration (2

PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF PENTAZOCINE AND NALOXONE TABLETS Addiction, Abuse, and Misuse Because the use of Pentazocine and Naloxone Tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [ see <WARNINGS ]
Life-Threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of Pentazocine and Naloxone Tablets, especially during initiation or following a dosage increase
To reduce the risk of respiratory depression, proper dosing and titration of Pentazocine and Naloxone Tablets are essential [ see <WARNINGS ]
Accidental Ingestion Accidental ingestion of even one dose of Pentazocine and Naloxone Tablets, especially by children, can result in a fatal overdose of Pentazocine Hydrochloride [ see <WARNINGS ]

Clinical Trial Data

No head-to-head clinical studies found for ACAMPROSATE CALCIUM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE.

ACAMPROSATE CALCIUM vs PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ACAMPROSATE CALCIUM: DailyMed label · FAERS adverse events · ClinicalTrials.gov
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE: DailyMed label · FAERS adverse events · ClinicalTrials.gov